New State Guidance on Resuming Normal Operations After the Public Health Emergency
On Thursday, January 21 State Health and Value Strategies hosted a webinar on the long-awaited guidance to state Medicaid and CHIP agencies on resuming normal operations following the end of the COVID-19 public health emergency. During the webinar experts from Manatt Health discussed the sub-regulatory guidance and the implications for states, in light of the recent public health emergency renewal by Secretary Azar. The webinar reviewed the expectations laid out in the guidance related to timelines, consumer communications, and fair hearing processes for redetermining Medicaid eligibility for those who have had their coverage continuously maintained as a condition of receiving the temporary 6.2 percent FMAP increase under the Families First Coronavirus Response Act. Additionally, presenters discussed the expected processes and timelines for terminating, or making permanent where allowable, temporary federal flexibilities that were obtained.
Click here for companion issue brief
Click here for webinar recording
CMS Guidance to States on Resuming Public Health Program Operations Post the COVID-19 Public Health Emergency
On December 22, 2020, the Centers for Medicare and Medicaid Services released long-awaited guidance to state Medicaid and CHIP agencies on resuming normal operations following the end of the COVID-19 public health emergency. This issue brief provides a high-level summary of the CMS guidance related to: (1) conducting redeterminations for Medicaid enrollees who were continuously enrolled; (2) terminating, or extending where appropriate, temporary flexibilities; and (3) developing a consumer and provider communication strategy.
The ACA in Maryland: A Case Study in Successful Bipartisan Innovation
The Affordable Care Act (ACA) sets up a structure with key roles for both federal and state policymakers. From establishing a state-based marketplace to a temporary Maryland supplemental reinsurance program, Maryland has taken steps to make health insurance more affordable. This case study describes the measures taken by the state to improve affordability and coverage, identifies unique program design features, and discusses their bipartisan appeal as experienced in Maryland. Maryland’s efforts can serve as a helpful framework for other similarly situated states seeking to address pressing health coverage affordability issues.
Omnibus Funding Package with COVID-19 Relief, Health Care Extenders, and Surprise Billing Ban
After a dynamic few weeks of negotiations, President Trump signed into law on December 27, 2020 a nearly 6,000-page legislative package (The Consolidated Appropriations Act, 2021) that includes government appropriations through September 30, 2021; COVID-19 relief funding and targeted policy changes, a subset of which impact health programs; extensions of expiring health programs; a ban on surprise billing; and an amalgam of odds-and-ends health policy provisions. This analysis includes a summary of those health care provisions.
The COVID-19 Relief Package and the “No Surprises Act”: Implications for States
In the waning days of 2020, Congress enacted a $900 billion COVID-19 relief package and government funding bill. Included in the measure is the “No Surprises Act,” which contains new protections for consumers from surprise medical bills from out-of-network providers. State Health & Value Strategies hosted a webinar during which experts from Georgetown University’s Center on Health Insurance Reforms, Manatt Health, and tax expert Jason Levitis reviewed the provisions of this legislation and their implications for states. The webinar reviewed the No Surprises Act and provided an overview of the next steps for implementing the federal balance billing protections and what the law will mean for state-level protections. Additionally, presenters discussed a number of other key health care provisions, including state and locality funding for COVID-19 vaccine distribution and testing as well as policy changes to the Provider Relief Fund, and the impact of additional unemployment compensation and relief payments on eligibility for financial assistance for health coverage.
Supporting Children and Youth with Special Health Care Needs During COVID-19
On Tuesday, December 15 State Health and Value Strategies hosted a webinar on how states can support children and youth with special health care needs during COVID-19. The COVID-19 pandemic has created significant health and economic hardships for many children and families. Children who receive health services in school settings to support their education are losing access to those services. In addition, a pre-COVID-19 shortage of home health providers has worsened due to the pandemic, placing a significant burden on families who rely on home health services. The result can lead to gaps in care and caregiver burnout, putting children and youth with special health care needs at risk of regression and long-term negative health outcomes. Recognizing these risks, states and the federal government have broadly expanded telehealth coverage, established continuous coverage requirements and eased regulatory requirements for delivery of services. The webinar, produced by Manatt Health with the American Academy of Pediatrics, Family Voices, and the Georgetown Center for Children and Families with funding from the Robert Wood Johnson Foundation and the Lucile Packard Foundation for Children’s Health, explored strategies for state Medicaid agencies to enforce coverage requirements and make permanent the temporary regulatory flexibilities that have expanded access to services during the pandemic.
Click here for webinar recording
State Strategies for Overcoming Barriers to Advance Health Equity
The COVID-19 pandemic has highlighted longstanding health inequities which have resulted in an increased risk of sickness and death for people of color. The crisis has also propelled a nationwide focus on understanding and addressing health inequities. This issue brief explores impediments and accelerants to advancing health equity as states are increasingly being called upon to drive change.
Screening for Social Risk Factors Webinar Series
State Health and Value Strategies hosted a two-part webinar series on screening Medicaid members for social risk factors. State Medicaid agencies are increasingly recognizing the impact that non-medical factors, such as social risk factors, have on health. Social risk factors are adverse social conditions which create barriers to health for individuals, such as food insecurity and homelessness. The first webinar reviewed key terms, screening tools, and design decisions for states interested in screening Medicaid managed care members for social risk factors. The second webinar, explored adopting a measure to assess social risk factor screening rates.
Click here for the Slide Deck for Part I
Click here for the Recording for Part I
Changes in the Coverage Environment During COVID-19: State Strategies to Support Enrollment
On Friday, October 30, State Health & Value Strategies hosted a webinar during which experts from Manatt Health and GMMB reviewed the trajectory of 2020 Medicaid enrollment growth to date and provide effective strategies related to communication with members and coordination across state Medicaid agencies and Marketplaces to support coverage access and retention in this dynamic environment.
Developing a Social Risk Factor Screening Measure
This issue brief is designed as a resource for states looking to adopt a measure to assess social risk factor screening rates. It is the result of a series of convenings that the authors facilitated with three states—Massachusetts, Oregon, and Rhode Island—which helped them consider, discuss, and share perspectives related to the development of their own social risk factor screening process measures. The issue brief looks at the progress these states and North Carolina have made in developing their own social risk factor screening measures and highlights considerations for other states either planning to adopt an existing or develop a new screening measure.